{"database": "lobbying", "table": "lobbying_activities", "rows": [[2349704, "023b9ca5-5f0b-4928-977c-60cc2448dde1", "Q3", "VAN SCOYOC ASSOCIATES", 39837, "ZEBRA TECHNOLOGIES CORP.", 2019, "third_quarter", "PHA", "Public Law 113-54, Drug Quality and Security Act, Drug labeling implementation", "HOUSE OF REPRESENTATIVES,SENATE", 10000, null, 0, 0, "2019-10-18T10:20:46.467000-04:00"]], "columns": ["id", "filing_uuid", "filing_type", "registrant_name", "registrant_id", "client_name", "filing_year", "filing_period", "issue_code", "specific_issues", "government_entities", "income_amount", "expense_amount", "is_no_activity", "is_termination", "received_date"], "primary_keys": ["id"], "primary_key_values": ["2349704"], "units": {}, "query_ms": 57.837566011585295, "source": "Federal Register API & Regulations.gov API", "source_url": "https://www.federalregister.gov/developers/api/v1", "license": "Public Domain (U.S. Government data)", "license_url": "https://www.regulations.gov/faq"}